X-ray crystallography

Tomorrow's innovations will come from autonomous labs that slash discovery time, and SLAC's facilities are taking the lead in a new collaboration with Stanford, other national labs, universities, and industry.

Their strategy revealed new details that open the door to designing proteins with powerful abilities that could ultimately benefit medicine and manufacturing. 

Researchers used X-ray lasers to control a modified cardiovascular drug with light and captured snapshots showing how it binds to proteins.

Making ‘magic’ happen with bright X-rays, SLAC’s Silvia Russi takes us into the world of a beamline scientist. 

Derek Mendez and Xueli “Sherry” Zheng aim to accelerate drug discovery and improve energy storage.

X-rays unveil new molecular structure details that will help researchers design novel drug therapies to address antibiotic resistant bacteria.

Oxidizing chemicals break this cellular power plant into useless bits, leading to  Parkinson’s disease, ALS, heart disease, diabetes, cancer and more. A small molecule could block the process.

The new findings highlight the need for ongoing monitoring of H5N1’s evolution in nature. 

For nearly 50 years, Hodgson has illuminated the synchrotron radiation community through his pioneering research, innovations, leadership, advocacy and mentorship at the Stanford Synchrotron Radiation Lightsource.

The high-energy upgrade will keep the U.S. at the forefront of X-ray science and technology, allowing researchers to advance fields such as sustainability, human health and quantum information.

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs for the autoimmune disorder.